Skip to main content

Advertisement

Table 6 In vitro antifungal agent susceptibilities of Candida and Cryptococcus isolates collected by the SENTRY Program in 2006 to 2007 [39].

From: Epidemiology and antifungal resistance in invasive candidiasis

Species (no. of isolates) and drug MIC50/MIC90 (μg/ml) MIC range (μg/ml)   % by categorya  
    S SDD R b
C. parapsilosis (238)      
Anidulafungin 2/2 0.03-4 95.4 - 4.6
Caspofungin 0.5/1 0.06-4 99.6 - 0.4
Amphotericin B 1/1 0.25-1 99.6 - 0.4
5-FC ≤0.5/≤0.5 ≤0.5- > 64 98.7 (0.0) 1.3
Fluconazole 1/4 ≤0.5-32 96.6 3.4 0.0
Itraconazole 0.25/0.25 ≤0.015-2 40.8 57.1 2.1
Posaconazole 0.12/0.25 ≤0.06-1 - - -
Voriconazole ≤0.06/0.12 ≤0.06-2 99.6 0.4 0.0